Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1,270,878
-
Shares change
-
+38,830
-
Total reported value, excl. options
-
$4,575,161
-
Value change
-
+$113,597
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$3.60
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2024
13 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q4 2024.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,270,878 shares
.
Largest 10 shareholders include PINNACLE ASSOCIATES LTD (489,693 shares), VILLERE ST DENIS J & CO LLC (483,867 shares), BROWN ADVISORY INC (119,465 shares), AMH Equity Ltd (116,500 shares), UBS Group AG (22,208 shares), Pathstone Holdings, LLC (17,000 shares), RENAISSANCE TECHNOLOGIES LLC (10,600 shares), WELLS FARGO & COMPANY/MN (8,405 shares), BANK OF AMERICA CORP /DE/ (2,500 shares), and NATIONAL BANK OF CANADA /FI/ (250 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.